TRPM2 and non-small cell lung carcinoma: Using immunofluorescence (IF) staining, we detected reduced cell membrane TRPM2 expression in EGFRm NSCLC cells exposed to osimertinib (Figure 1F) and also decreased TRPM2 expression in PC‐9 xenografted tissue exposed to osimertinib (Figure 1G).